Maggie® 5.0

Maggie® 5.0 is an innovative, large-volume, cartridge-based autoinjector technology built with our market-proven Needle Isolation Technology (NIT®).

<p>Maggie 5.0 ml autoinjector with the cap off</p>

Meet Maggie® 5.0 mL

Maggie5.0_Horizontal_去兩環_20230509

For specific and large-volume formulation

Maggie® 5.0 mL accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors.

Specifications

Viscosity
high
Volume
5.0 ml
Device type
Disposable autoinjector
Primary container
Cartridge with pre-installed needle (NIT®)
Route of administration
Subcutaneous
Connectivity
No
Dosage type
Fixed dose | Optional automated priming and titration
Activation method
Needle cover
Injection feedback
Continuous audible clicks, viewing window
Customization
Yes
Download specifications

Needle Isolation Technology (NIT)

NIT® is a market-proven, pre-attached needle technology for cartridge-based injections that eliminates the need for patients to manually attach the needle. NIT provides complete control of cannula gauge and length to support target injection time and injection depth.  

The first NIT-enabled autoinjector received regulatory approval in 2017 for a metabolic treatment. In 2024, a second device was approved for treatment of two dermatological conditions. 

NIT-20250708

Advancing large-volume subcutaneous autoinjection

SHL Medical introduced the Maggie® 5.0 mL autoinjector in 2022, expanding fill volume capacity to complement the 3.0 mL variant, giving pharma partners greater flexibility as subcutaneous therapies continue to evolve. 

Explore Alliances

Cartridge-based solutions

Maggie® 5.0 is designed for large-volume subcutaneous drug delivery using a 5.0 mL cartridge with pre-installed needle.  

Maggie 5mL cartridge-based-solutions-c

Supply chain partnerships

Maggie® 5.0 is supported by an integrated supply chain, from primary container components and drug filling to final device assembly.  

supply-chain-partnerships-e6e7e8